Dell Partners with University of Limerick to Develop AI Platform for Faster, Personalized Cancer Diagnosis and Treatment
-
Dell is partnering with the University of Limerick to develop an AI platform for cancer research.
-
The goal is to advance predictive and diagnostic cancer research capabilities using AI.
-
The platform aims to provide researchers with information to accelerate diagnosis and treatment for B-cell lymphoma patients.
-
AI will help speed up cancer biomarker testing and enable personalized therapies based on tumor characteristics.
-
The partnership also aims to promote better understanding of cancer development and cell behavior.